Characterization of AAV vector particle stability at the single-capsid level
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Virus families have evolved different strategies for genome uncoating, which are also followed by recombinant vectors. Vectors derived from adeno-associated viruses (AAV) are considered as leading delivery tools for in vivo gene transfer, and in particular gene therapy. Using a combination of atomic force microscopy (AFM), biochemical experiments, and physical modeling, we investigated here the physical properties and stability of AAV vector particles. We first compared the morphological properties of AAV vectors derived from two different serotypes (AAV8 and AAV9). Furthermore, we triggered ssDNA uncoating by incubating vector particles to increasing controlled temperatures. Our analyses, performed at the single-particle level, indicate that genome release can occur in vitro via two alternative pathways: either the capsid remains intact and ejects linearly the ssDNA molecule, or the capsid is ruptured, leaving ssDNA in a compact entangled conformation. The analysis of the length distributions of ejected genomes further revealed a two-step ejection behavior. We propose a kinetic model aimed at quantitatively describing the evolution of capsids and genomes along the different pathways, as a function of time and temperature. This model allows quantifying the relative stability of AAV8 and AAV9 particles.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal denaturation of rAAV involves genome ejection and capsid disruption85.”
From An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species (2024) · cites this paper as [85]
Citations
Cites
Stochastic Processes in Physics and Chemistry
(2007) · Elsevier eBooks · doi:10.1016/b978-0-444-52965-7.x5000-4 · Cited by 8,692
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · cited 2×
“Adeno-associated virus (AAV) is a nonpathogenic parvovirus that has emerged as one of the most popular tools for in vivo gene transfer in particular gene therapy [1].”
BackgroundVAN KAMPEN, N. G. (2007) · Stochastic Processes in Physics and Chemistry · doi:10.1016/b978-044452965-7/50006-4 · Cited by 472
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Asokan, A., Schaffer, D. V., & Jude Samulski, R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.287 · Cited by 465
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358 · cited 2×
“It is therefore conceivable to state that efficiency of cell transduction is at least depending on efficiency of vector internalization, including nuclear delivery and efficiency of uncoating in the nucleus [5, 6].”
BackgroundWobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 3×
“After heating at the indicated temperature, AAV particles were bound on the membrane under non-denaturing conditions and incubated with the B1 antibody, which recognizes the internal part of the three VP capsid proteins [15].”
MethodInfluentialIntracellular transport of recombinant adeno-associated virus vectors
Nonnenmacher, M., & Weber, T. (2012) · Gene Therapy · doi:10.1038/gt.2012.6 · Cited by 258
Polymer escape through a nanopore
Muthukumar, M. (2003) · The Journal of Chemical Physics · doi:10.1063/1.1553753 · Cited by 248
Factors Influencing Recombinant Adeno-Associated Virus Production
Salvetti, A., Orève, S., Chadeuf, G., Favre, D., Cherel, Y., Champion-Arnaud, P., David-Ameline, J., & Moullier, P. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.5-695 · Cited by 241
Self-citation
Cited by
Journey to the Center of the Cell: Tracing the Path of AAV Transduction
Dhungel, B. P., Bailey, C. G., & Rasko, J. E. J. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.010 · Cited by 122
Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions
Riyad, J. M., & Weber, T. (2021) · Gene Therapy · doi:10.1038/s41434-021-00243-z · Cited by 118
Challenges in scaling up AAV-based gene therapy manufacturing
Jiang, Z., & Dalby, P. A. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.04.002 · Cited by 116
“Other studies 15 min at 21–80°C [42] 30 min at 37, 55, and 65°C [43] 24 h at 20°C or 20 min at 75°C [44] 30 days at 45°C [45] 10 days at 40°C [46] 7–60 days at 25 and 40°C [47] 14 days at 4, 40, and 50°C [48] 10 min at 74°C [49] 1–3 days at 60°C [50]”
Rossi, A., Dupaty, L., Aillot, L., Zhang, L., Gallien, C., Hallek, M., Odenthal, M., Adriouch, S., Salvetti, A., & Büning, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-40071-1 · Cited by 85
Self-citationBarnes, L. F., Draper, B. E., Chen, Y., Powers, T. W., & Jarrold, M. F. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.08.002 · Cited by 92
Metadata
- Authors
- Bernaud, J., Rossi, A., Fis, A., Gardette, L., Aillot, L., Büning, H., Castelnovo, M., Salvetti, A., & Faivre-Moskalenko, C.
- Affiliations
- Lyon 1 Université (FR)
- École Normale Supérieure de Lyon (FR)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Castelnovo, Martin
- Salvetti, Anna
- Faivre-Moskalenko, Cendrine
- ORCID
- Venue
- Journal of Biological Physics
- Published
- 2018-04-14
- Volume
- 44
- Issue
- 2
- Pages
- 181-194
- ISSN
- 0092-0606 (ISSN-L)
- 1573-0689
- PMC
- PMC5928021
- OpenAlex
- W2796959653
- Cited by
- 83
- References
- 26
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 11 · 2023: 15 · 2022: 10 · 2021: 12 · 2020: 4 · 2019: 7 · 2018: 2
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Biological Physics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0048)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- adeno-associated virus vectors, AAV8, AAV9, capsid stability, kinetic model, gene therapy vectors, single-particle characterization
- MeSH terms
- Dependovirus, Capsid, Genetic Vectors, Thermodynamics, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of AAV vector particle stability at the single-capsid level. https://app.cochat.ai/papers/10.1007/s10867-018-9488-5
- The paper
- Bernaud, J., Rossi, A., Fis, A., Gardette, L., Aillot, L., Büning, H., Castelnovo, M., Salvetti, A., & Faivre-Moskalenko, C. (2018). Characterization of AAV vector particle stability at the single-capsid level. Journal of Biological Physics. https://doi.org/10.1007/s10867-018-9488-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.